Abstract
Primary cardiac neoplasms are rare, and are more commonly benign than malignant. However, metastases are by far the most common cardiac neoplasms. MRI allows evaluation of myocardial infiltration, pericardial involvement and/or extracardiac extension. MRI overcomes the usual limitations of echocardiography and assesses more accurately changes in cardiac function. Specific tumoral characterization is only possible in cases of myxoma, lipoma, fibroma and hemangioma. Suggestive features of malignancy are right side location, extracardiac extension, inhomogeneity in signal intensity of the tumor and pericardial effusion. The use of intravenous contrast material improves tumor characterization and depiction of tumor borders. MRI also allows differentiation of tumor from other nontumoral masses such as intracavitary tumors or fibromuscular elements of the posterior wall of the right atrium.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Metastases are by far the most common cardiac neoplasms and primary cardiac neoplasms are rare [1]. Imaging, traditionally performed with sonography, allows detection and analysis of their functional effect [2]. However, dependence on an adequate acoustic window and suboptimal visualization of extracardiac extension, limits evaluation. Although EKG-gated multislice computed tomography (CT) will undoubtedly have an important role in the evaluation of cardiac masses, magnetic resonance imaging (MRI) is presently the modality of choice in evaluating cardiac tumors. Excellent contrast resolution and multiplanar capability allow optimal evaluation of myocardial infiltration, pericardial involvement and/or extracardiac extension [3].
The use of MRI in the evaluation of cardiac tumors is reviewed in this article, and the features typically associated with the different neoplasms and the clinical importance of this imaging technique are emphasized.
Tumor characterization
Although the signal intensity characteristics of benign and malignant tumors are often similar [4], MRI can be diagnostic in patients with cardiac lipomas, fibromas and angiomas [5]. MRI is also useful in determining cystic, necrotic, lipomatous and hemorrhagic components within a mass. The presence of tumor signal heterogeneity, necrosis, wide point of attachment, involvement of more than one chamber, extracardiac extension and hemorrhagic pericardial effusion are suspicious for malignancy [1, 5–7]. In a recent study the sensitivity and specificity for malignancy of these manifestations were not optimal with the more accurate predictors of malignancy being right-sided location, inhomogeneity of tumor tissue and presence of a pericardial effusion [8]. Additionally, the use of intravenous contrast agent has been reported to improve differentiation between benign and malignant tumors [9]. Table 1 shows the most important clinical and MRI features of primary cardiac tumors.
Benign cardiac tumors
Primary benign cardiac neoplasms, although rare, are more common than primary malignant cardiac neoplasms [10]. Clinical symptoms are typically related to the location of the cardiac tumor and include arrhythmias, emboli, obstruction of blood flow, and alteration of normal myocardial contractility [1, 11]. MRI is useful not only in detection and diagnosis, but also in providing information that can assist surgical treatment.
Myxoma
Myxomas are the most common cardiac tumors and account for 25–50% of all primary cardiac tumors [1, 10]. They usually occur in adults of 30–60 years of age [11] and typically arise from the interatrial septum or the fossa ovalis, although they can arise from any endocardial area [12]. They are usually located in the left atrium (75%) or right atrium (20%) and rarely in the ventricles [11]. Uncommonly, growth occurs through the fossa ovalis resulting in tumor into both atria [12]. Myxomas rarely can show malignant changes [13].
Myxomas typically manifest as intracardiac masses attached to the endocardium by a narrow pedicle although broad-based and nonmobile masses have been reported [11, 12]. The masses are usually isointense to the myocardium on T1-weighted images, hyperintense on T2-weighted images and show heterogeneous contrast enhancement (Fig. 1) [1, 14, 15]. Less commonly myxomas can be heterogeneous on both T1- and T2-weighted images due to the presence of calcification, hemorrhage or necrosis [11, 15]. Cine MRI reveals low signal intensity mobile masses, and usually allows better visualization of the endocardial attachment than T1- and T2-weighted images [15].
Papillary fibroelastoma
In surgical series, papillary fibroelastomas account for 10% of all primary cardiac tumors [7]. Histologically, papillary fibroelastomas are avascular papillomas lined by endothelium [11]. Although they can originate from any endocardial surface, they are typically in the left chambers attached to the cardiac valves (>90% of cases) [11]. They are usually solitary and less than 20 mm in diameter. Most are incidentally detected and sonography can suggest the diagnosis when they arise from a valve [16, 17]. MRI can be helpful when the origin is not typical [10]. On T2-weighted images, they manifest as small hypointense masses [7]. The smaller papillary fibroelastomas may not be visualized on routine imaging sequences [11], but cine MRI can improve detection due to the presence of peritumoral turbulent blood flow [18].
Lipoma
Cardiac lipomas are encapsulated tumors that usually originate from the epicardium, although myocardial or endocardial origins have been reported [7]. They occur across a wide age range and patients are typically asymptomatic [11]. MRI is diagnostic as tumor signal intensity is parallel to fat on all sequences [7, 11]. Cardiac lipomas need to be differentiated from lipomatous hypertrophy of the interatrial septum. Lipomatous hypertrophy of the interatrial septum is a non-neoplastic abnormality that manifests as fat in the atrial septum that exceeds 2 cm in transverse diameter and typically spares the fossa ovalis (Fig. 2) [10, 11].
Rhabdomyoma
Cardiac rhabdomyomas are myocardial hamartomas and up to 50% occur in association with tuberous sclerosis [7]. Most are diagnosed by sonography in the prenatal period and are most frequently located in the myocardium of the ventricles [10]. Multiplicity is common, and the size of the tumors is variable [10]. Rhabdomyomas tend to disappear spontaneously although, occasionally, resection is necessary to treat arrhythmias or left ventricular outflow obstruction [7]. Multiple rhabdomyomas smaller than 1 mm (rhabdomyomatosis) can manifest as diffuse myocardial thickening [7]. Rhabdomyomas are iso- or hyperintense to myocardium on T1-weighted images and slightly hyperintense on T2-weighted images [19, 20]. The borders of the tumor are generally better depicted on proton density-weighted images and postcontrast images [15]. Myocardial tagging sequences allow identification as noncontractile myocardium [21].
Fibroma
Fibromas, rare congenital tumors usually diagnosed in children under 1 year of age, have been described in adults [10]. They are fibrous masses typically located in the myocardium, most commonly in the ventricular septum or the left ventricle free wall [10]. Calcification is common, and is an important feature in differentiating fibromas from rhabdomyomas [15]. Surgical resection is usually necessary, as they can cause arrhythmias or sudden death [10]. Fibromas have a characteristic appearance on MRI. They are iso- to slightly hyperintense compared to myocardium on T1-weighted images and hypointense on T2-weighted images due to their fibrous composition and presence of calcification [7, 15]. Fibromas have variable patterns of enhancement [7, 11, 15]. However, postcontrast images can be useful in evaluation because enhancement of compressed peritumoral myocardium allows an assessment of the tumor borders [9, 22].
Hemangioma
Cardiac hemangiomas account for 5–10% of benign cardiac tumors [7]. They are classified according to the size of their vascular channels into capillary, cavernous or venous hemangiomas [1]. They occur in any cardiac location, including the pericardium [23]. They are isointense compared to myocardium on T1-weighted images and hyperintense on T2-weighted images (Fig. 3A) [1, 7]. Cardiac hemangiomas enhance intensely with contrast and (Fig. 3B) this can be inhomogeneous because of interspersed calcification and fibrous septa within the masses [24].
Paraganglioma
Cardiac paragangliomas are rare tumors that originate from neuroendocrine cells that are usually located in the left atrium [11]. They occur more commonly in young adults and patients are typically symptomatic due to catecholamine overproduction. Cardiac paragangliomas are typically iso- or hypointense to myocardium on T1-weighted images and hyperintense on T2-weighted images [25]. Other features, such as hyperintensity on T1-weighted images (related to intratumoral hemorrhage) [11], or hypointensity on T2-weighted sequences [26], have been reported. Cardiac paragangliomas are hypervascular tumors and accordingly enhance with contrast [25].
Other benign cardiac tumors
Intravenous leiomyomas, benign smooth muscle tumors originating either from a uterine myoma or from a vessel wall, can extend into the heart [27]. They are rare neoplasms that usually occur in premenopausal women and usually manifest as a mass in the IVC that extends into the right atrium [5]. Intravenous/intracardiac leiomyomas are isointense to muscle on all pulse sequences [5]. MRI, due to its large field of view, can allow accurate localization and determination of origin [27].
Cardiac bronchogenic cysts are rare, but can manifest as cystic masses in the interatrial septum (Fig. 4) [14]. Differential diagnosis includes a hydatid cyst, although these cystic masses tend to have a solid component and can be calcified [28].
Malignant cardiac tumors
Metastases are the most common cardiac malignancy and primary malignant cardiac tumors are rare [5, 29]. The most common primary cardiac malignancies are sarcomas and lymphomas [7]. Malignant cardiac tumors have a higher incidence in the right chambers and frequently show extracardiac extension [8]. MRI is the modality of choice in the evaluation of these tumors as it is superior to sonography in the evaluation of the right chambers of the heart and in the assessment of extracardiac extension [15, 30].
Sarcomas
Sarcomas are the most common primary cardiac malignancy and the second most common primary cardiac tumor after myxoma [7]. They are rare mesenchymal tumors and the most common subtype is an angiosarcoma [6]. With the exception of rhabdomyosarcomas, which usually occur in infants, they typically occur in adults and present with cardiopulmonary symptoms [7].
Angiosarcoma
Angiosarcomas usually occur in middle-aged men [6]. They are generally located in the right atrium, although they can extend to the pericardium or have a pericardial origin in patients with Kaposi’s sarcoma [6]. The appearance of angiosarcomas on MRI is suggestive of the diagnosis. The masses have marked signal heterogeneity on T1- and T2-weighted images with hyperintense foci corresponding to intratumoral hemorrhage (Fig. 5) [1, 6, 15]. On GE sequences, hemorrhagic foci manifest as areas of low signal intensity. There are also flow voids within the mass on both T1- and T2-weighted images, which are hyperintense on GE, due to vascular structures [1]. This feature has been described as a “cauliflower” appearance [1, 15]. Angiosarcomas typically show diffuse and intense contrast enhancement that has been described as a “sun-ray” appearance [15].
Undifferentiated sarcoma
This group of cardiac sarcomas have no specific histological features. Their incidence has decreased with the advent of immunohistochemical staining and electron microscopy. They are usually located in the left atrium [6] and have no specific imaging features, appearing either as focal polypoid myocardial masses [31] or as infiltrating intracardiac lesions [32].
Rhabdomyosarcoma
Cardiac rhabdomyosarcomas usually occur in young patients, without any chamber predilection [6]. They are typically located in the myocardium, and have a tendency to arise from the valves [30]. Large areas of necrosis within the tumor and secondary involvement of the pericardium are common findings [6].
Osteosarcoma
Primary cardiac osteosarcomas are commonly located in the left atrium in contradistinction to metastatic osteosarcomas that usually involve the right atrium. CT is very useful in evaluation because it typically shows calcification [10]. The differential includes myxoma, and MRI generally allows confident differentiation of these tumors.
Other sarcomas
All of these tumors are very rare, typically arise in the left atrium and generally have a non-specific appearance on MR imaging [6]. Malignant fibrous histiocytomas occur in middle-aged women, have a predilection for the posterior wall of the left atrium and typically involve the pulmonary veins (Fig. 6) [30]. Leiomyosarcomas tend to invade the pulmonary veins or the mitral valve and rarely are calcified [6]. Fibrosarcomas can have intratumoral necrosis and a heterogeneous appearance on T1-weighted images [30]. Liposarcomas are extremely rare, can be locally invasive with pericardial or valvular involvement and rarely contain intratumoral macroscopic fat [6].
Lymphoma
Primary cardiac lymphomas are rare, and much less frequent than secondary cardiac involvement by systemic lymphomas [7]. They are usually aggressive B-cell lymphomas and there is a higher incidence in immunocompromised patients [6]. They usually arise in the right atrium and an associated pericardial effusion is common [7]. Features that can be useful in suggesting the diagnosis and differentiating these tumors from cardiac sarcomas are the absence of necrosis and less frequent involvement of the cardiac valves and intracavitary extension [10]. The masses are hypo- or isointense compared to the myocardium on T1-weighted images (Fig. 7) and iso- or hyperintense on T2-weighted images [6, 7]. Contrast enhancement varies from minimal to intense and homogeneous to heterogeneous [6].
Metastatic heart disease
Metastases to the heart and pericardium are 20–40 times more frequent than primary cardiac malignancies [30]. They occur late in the course of a malignancy and 30% of patients have symptoms related to impairment of cardiac function [29]. Cardiac metastases occur via lymphatic, hematogenous, direct/contiguous or transvenous extension [29, 30]. Lymphatic extension, particularly frequent in lung, breast and hematological malignancies, is the most common pathway that results in cardiac involvement [30] (Fig. 8A). Multiple microscopic epicardial implants follow a retrograde route through mediastinal lymphatics to the heart and typically manifest as a pericardial effusion. Although MRI allows the detection of small pericardial effusions and can indicate that the effusion is hemorrhagic, pericardiocentesis is required for diagnosis. Hematogenous myocardial or epicardial implants usually reach the heart via the coronary arteries, although dissemination through the IVC is also possible (Fig. 8B) [29, 30]. Direct extension is typical of primary lung carcinomas, but can occur with breast and esophageal carcinomas (Fig. 8C), thymomas, and lymphomas [29, 30]. On MRI, obliteration of the fat plane between the tumor and pericardium is suggestive of invasion [30]. Transvenous cardiac extension via the IVC is typical of renal cell carcinomas but extension can occur via the suprahepatic veins and the IVC with hepatocellular carcinomas, cholangiocarcinomas and adrenal carcinomas (Fig. 8D) [29]. The pulmonary veins and SVC are potential pathways for intracardiac extension in patients with primary lung carcinomas. MRI allows delineation of tumor extension and depicts the extent of the tumor/thrombus in the atrium, a factor important in surgical planning. In this regard, postcontrast images can be useful in differentiating tumor from thrombus [30].
The heart can also be involved in paraneoplastic syndromes, most commonly in carcinoid heart disease which usually presents as right-sided valvular heart disease. MRI allows its accurate evaluation [33].
Conclusions
MRI allows comprehensive evaluation of cardiac tumors and often allows a diagnosis of myxoma, fibroma, lipoma and hemangioma to be suggested. Postcontrast sequences can improve tumor characterization and allow a better depiction of tumor borders. MRI has an important role in defining the intracardiac extent of malignancies, such as sarcomas and lymphomas, and in evaluating the presence and extent of extracardiac extension.
References
Krombach GA, Saeed M, Higgins CB (2003) Cardiac masses. In: Higgins CB, de Roos A (eds) Cardiovascular MRI and MRA. Lippincott Williams & Wilkins, Philadelphia, PA, pp 136–154
Lobo A, Lewis JF, Conti CR (2000) Intracardiac masses detected by echocardiography: case presentations and review of the literature. Clin Cardiol 23(9):702–708
Brown JJ, Barakos JA, Higgins CB (1989) Magnetic resonance imaging of cardiac and paracardiac masses. J Thorac Imaging 4:58–64
Schmidt HC, Tscholakoff D, Hricak H, Higgins CB (1985) MR image contrast and relaxation times of solid tumors in the chest, abdomen and pelvis. J Comput Assist Tomogr 9:738–748
Frank H (2002) Cardiac and paracardiac masses. In: Manning WJ, Pennell DJ (eds) Cardiovascular magnetic resonance. Churchill Livingstone, Philadelphia, PA, pp 342–354
Araoz PA, Eklund HE, Welch TJ, Breen JF (1999) CT and MR imaging of primary cardiac malignancies. Radiographics 19(6):1421–1434
Grebenc ML, Rosado-de-Christenson ML, Burke AP, Green CE, Galvin JR (2000) Primary cardiac and pericardial neoplasms: radiologic–pathologic correlation. Radiographics 20(4):1073–1103
Hoffmann U, Globits S, Schima W, et al (2003) Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol 92(7):890–895
Funari M, Fujita N, Peck WW, Higgins CB (1991) Cardiac tumors: assessment with Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15(6):953–958
Burke A, Virmani R (1996) Tumors of the heart and great vessels, 3rd series, fasc 16. Armed Forces Institute of Pathology, Washington, DC, pp 1–98
Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JF (2000) CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 20(5):1103–1319
Grebenc ML, Rosado-de-Christenson ML, Green CE, Burke AP, Galvin JR (2002) Cardiac myxoma: imaging features in 83 patients. Radiographics 22(3):673–689
Eckhardt BP, Dommann-Scherrer CC, Stuckmann G, Zollikofer CL, Wentz KU (2003) Giant cardiac myxoma with malignant transformed glandular structures. Eur Radiol 13(9):2099–2102
Luna A, Ribes R, Caro P (2003) Tumores y otras masas cardiacas. In: Tardaguila FM, Ferreiros J (eds) Imagen cardiovascular avanzada: RM y TC. Panamericana, Madrid, pp 79–85
Kaminaga T, Takeshita T, Kimura I (2003) Role of magnetic resonance imaging for evaluation of tumors in cardiac regions. Eur Radiol 13(4):1–10
Sun JP, Asher CR, Yang XS (2001) Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation 103(22):2687–2693
Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB (1997) Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol 30(3):784–790
al-Mohammad A, Pambakian H, Young C (1998) Fibroelastoma: case report and review of the literature. Heart 79(3):301–304
Go RT, O’Donnell JK, Underwood DA, et al (1985) Comparison of gated cardiac MRI and 2D echocardiography of intracardiac neoplasms. AJR Am J Roentgenol 145(1):21–25
Winkler M, Higgins CB (1987) Suspected intracardiac masses: evaluation with MR imaging. Radiology 165(1):117–122
Bouton S, Yang A, McCrindle BW, Kidd L, McVeigh ER, Zerhouni EA (1991) Differentiation of tumor from viable myocardium using cardiac tagging with MR imaging. J Comput Assist Tomogr 15(4):676–678
Semelka RC, Shoenut JP, Wilson ME, Pellech AE, Patton JN (1992) Cardiac masses: signal intensity features on spin-echo, gradient-echo, gadolinium-enhanced spin-echo, and TurboFLASH images. J Magn Reson Imaging 2(4):415–420
Brodwater B, Erasmus J, McAdams HP, Dodd L (1996) Case report. Pericardial hemangioma. J Comput Assist Tomogr 20(6):954–956
Oshima H, Hara M, Kono T, Shibamoto Y, Mishima A, Akita S (2003) Cardiac hemangioma of the left atrial appendage: CT and MR findings. J Thorac Imaging 18(3):204–206
Hamilton BH, Francis IR, Gross BH, et al (1997) Intrapericardial paragangliomas (pheochromocytomas): imaging features. AJR Am J Roentgenol 168(1):109–113
Heufelder AE, Hofbauer LC (1996) Greetings from below the aortic arch! The paradigm of cardiac paraganglioma. J Clin Endocrinol Metab 81(3):891–895
Kocaoglu M, Bulakbasi N, Ugurel MS, Ors F, Tayfun C, Ucoz T (2003) Value of magnetic resonance imaging in the depiction of intravenous leiomyomatosis extending to the heart. J Comput Assist Tomogr 27(4):630–633
Ben-Hamda K, Maatouk F, Ben-Farhat M, et al (2003) Eighteen-year experience with echinococcosus of the heart: clinical and echocardiographic features in 14 patients. Int J Cardiol 91(2–3):145–151
Chiles C, Woodard PK, Gutierrez FR, Link KM (2001) Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics 21(2):439–449
Gilkeson RC, Chiles C (2003) MR evaluation of cardiac and pericardial malignancy. Magn Reson Imaging Clin N Am (1):173–186
Lazoglu AH, Da Silva MM, Iwahara M, et al (1994) Primary pericardial sarcoma. Am Heart J 127(2):453–458
Baumgartner RA, Das SK, Shea M, LeMire MS, Gross BH (1988) The role of echocardiography and CT in the diagnosis of cardiac tumors. Int J Cardiovasc Imaging 3(1):57–60
Mollet NR, Dymarkowski S, Bogaert J (2003) MRI and CT revealing carcinoid heart disease. Eur Radiol 13 [Suppl 4]:L14–L18
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luna, A., Ribes, R., Caro, P. et al. Evaluation of cardiac tumors with magnetic resonance imaging. Eur Radiol 15, 1446–1455 (2005). https://doi.org/10.1007/s00330-004-2603-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-004-2603-y